Target
Pro-glucagon
Ligand
BDBM142025
Substrate
n/a
Meas. Tech.
SPA Assay
pH
7.4±n/a
Ki
1855±n/a nM
Citation
 Didiuk, MFilipski, KJGuzman-Perez, ALee, ECPfefferkorn, JAStevens, BTu, M Quinolinyl glucagon receptor modulators US Patent  US8927577 Publication Date 1/6/2015 
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
  
Inhibitor
Name:
BDBM142025
Synonyms:
US8927577, 6
Type:
Small organic molecule
Emp. Form.:
C25H29N3O4
Mol. Mass.:
435.5155
SMILES:
COc1cccc2ccc(NC(CC(C)C)c3ccc(cc3)C(=O)NCCC(O)=O)nc12
Structure:
Search PDB for entries with ligand similarity: